Status:
COMPLETED
Value of an Intervention to Enhance Adherence in Glaucoma Patients
Lead Sponsor:
Aristotle University Of Thessaloniki
Collaborating Sponsors:
Alcon Research
Conditions:
Glaucoma
Eligibility:
All Genders
21-80 years
Phase:
PHASE4
Brief Summary
A one-year, randomized, attention placebo-controlled trial investigating the value of comprehensive adherence specific interventions, over the course of one year, to enhance adherence in both (a) newl...
Eligibility Criteria
Inclusion
- Newly diagnosed patients with glaucoma
- Suboptimally controlled patients with glaucoma
- Untreated baseline IOP greater than 21 mm Hg but less than 32 mm Hg
- Patients who have not responded satisfactorily to PGA therapy
- Patients who are about to have adjunctive therapy administered
- Patients who consent to participate in this trial
Exclusion
- Glaucoma patients with high pressure
- Advanced glaucoma
- Patients with side effects to PGA therapy
- Unwilling to participate
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
107 Patients enrolled
Trial Details
Trial ID
NCT00756184
Start Date
September 1 2007
End Date
September 1 2009
Last Update
September 28 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.